SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2021

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Assumptions Used to Estimate Fair Value

The fair value of the Company's stock options granted for the years ended December 31, 2021, 2020 and 2019 was estimated using the following weighted average assumptions:

	Year ended December 31,
	2021		2020		2019
Risk free interest		0.26%-1.14%		-		1.35%-2.51%
Dividend yields		0%		-		0%
Volatility		41.09%-50.62%		-		33.35%-34.32%
Expected term (in years)		4.00-4.04		-		4.22-4.26

Schedule of Stock-Based Compensation Expenses

During the year ended December 31, 2021, 2020 and 2019 the stock-based compensation for options were recognized in the consolidated statement of income (loss) in the following line items:

	Year ended December 31,
	2021		2020		2019
Cost of revenues of products	$	137	$	82	$	138
Cost of revenues of services		140		84		120
Research and development, net		304		279		280
Selling and marketing		422		287		448
General and administrative		301		550		1,149
	$	1,304	$	1,282	$	2,135

Employee [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Stock Option Activity

A summary of employee option balances under the 2008 Plan as of December 31, 2021 and changes during the year then ended are as follows:

	Number of options			Weighted-average exercise price *)		Weighted- average remaining contractual term (in years)		Aggregate intrinsic value (in thousands) *)
Outstanding at January 1, 2021		2,776,778		$	6.1		3.0	$	4,142
Granted		2,422,500		$	8.1
Exercised		(1,391,384	)	$	4.6
Forfeited and cancelled		(708,750	)	$	8.0
Outstanding as of December 31, 2021		3,099,144		$	7.8		4.5	$	1,737
Exercisable as of December 31, 2021		434,769		$	6.4		2.3	$	504

*) In January 2021 the Company distributed a cash dividend in the amount of $35,003 or $0.63 per share. All exercise prices were updated on a retrospective basis (See Note 11.c)

Schedule of Stock Option Activity by Exercise Price

The outstanding and exercisable options granted under the 2008 Plan as of December 31, 2021, have been separated into ranges of exercise price as follows:

Ranges of exercise price	Options outstanding as of December 31, 2021		Weighted average remaining contractual life (in years)		Weighted average exercise price		Options exercisable as of December 31, 2021		Weighted average exercise price of exercisable options
$3.51-5.07		137,893		0.7	$	3.8		137,893		3.8
$6.22-8.52		2,161,251		4.5	$	6.7		296,876		7.6
$9.92-11.92		800,000		5.3	$	11.5		-		-
		3,099,144		4.5	$	7.8		434,769		6.4